Newsletter Articles for the Topic: ‘developed’

MHT’s Finance Flash: Sanofi reported to offer $18B for Genzyme

MHT’s Bio Flash: Yale cell researchers win $2.5M NIH grants

Weekend Roundup

MHT’s Bio Flash: NxStage home products boost revenue

MHT’s Bio Flash: Genzyme profits drop as shortages continue

MHT’s Bio Flash: Taris names Duddu as CEO

Why up to 98% of cancer treatments fail

Choppy Seas for Shipping ETF; 5 Infrastructure ETFs for Upgrades; Copper and Nickel to See Higher Prices?

MHT’s Finance Flash: Millipore’s $7B buyout by Merck completed

MHT’s Bio Flash: Cubist drug passes Phase 2 safety test